Government resistance to aligning domestic patent law with international standards. Israel s parallel import policy threatens foreign company margins. Potential reduction in prices under new pricing system proposals. The country s extremely tense domestic and external situation, both in terms of political instability and the Palestinian-Israeli conflict, threatens long-term market stability. Increasing cooperation on health by Gulf Cooperation Council members may leave Israel more politically and economically isolated than ever. A sharp appreciation of the shekel could cause Israel s exports to become uncompetitive. Discriminatory healthcare coverage disadvantaging those with Palestinian parentage tarnishes Israel s standing in the international community.
...In July ----, Kantar Health, a leading global healthcare consulting and market research firm, announced it would expand its presence in Israel to better partner with companies in the rapidly growing life sciences industry. Kantar Health will offer marketing insights and real-world evidence solutions to the local biotech, medical technology and mHealth companies that populate Israel s hub of healthcare innovation. ...In July ----, Kantar Health, a leading global healthcare consulting and market research firm, announced it would expand its presence in Israel to better partner with companies in the rapidly growing life sciences industry. Kantar Health will offer marketing insights and real-world evidence solutions to the local biotech, medical technology and mHealth companies that populate Israel s hub of healthcare innovation. In August ----, Novartis announced it would support the development of a non-alcoholic steatohepatitis (NASH) drug by its Israeli partner BioLineRx. ...In August ----, Novartis announced it would support the development of a non-alcoholic steatohepatitis (NASH) drug by its Israeli partner BioLineRx. The arrangement sees BioLineRx, which Novartis works with to scout opportunities in Israel, in-license the NASH asset under its R&D framework.
...Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) and the EU s acceptance of Israel s good manufacturing practice certificates without the need for additional testing. New proactive policies promoting healthier diets and regulations against unhealthy products could reduce the country s disease burden in the medium to long term. ...